XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2018 $ 9,657 $ 6,052,161 $ (10,457,710) $ (4,395,892)
Balance, shares at Sep. 30, 2018 9,656,505      
Stock-based compensation 324,205 324,205
Issuance of common stock upon conversion of convertible promissory notes $ 839 1,920,881 1,921,720
Issuance of common stock upon conversion of convertible promissory notes, shares 839,179      
Issuance of warrants and reclassification of warrant liability upon conversion of convertible promissory notes 1,565,402 1,565,402
Issuance of warrants and reclassification of warrant liability upon conversion of convertible promissory notes, shares      
Issuance of common stock under 2019 and 2018 private placements $ 2,508 4,558,707 4,561,215
Issuance of common stock under 2019 and 2018 private placements, shares 2,508,179      
Issuance of warrants under 2019 and 2018 private placements 1,709,233 1,709,233
Issuance costs related to 2019 and 2018 private placements (1,168,679) (1,168,679)
Issuance of warrants to brokers related to 2019 and 2018 private placements 378,838 378,838
Issuance of common stock for consulting services $ 50 114,950 115,000
Issuance of common stock for consulting services, shares 50,000      
Granting of options previously recorded as a liability 38,696 38,696
Exercise of stock options $ 198 52,313 52,511
Exercise of stock options, shares 198,043      
Issuance of stock awards $ 11 24,990 25,001
Issuance of stock awards, shares 10,503      
Exercise of warrants $ 231 416,102 416,333
Exercise of warrants, shares 231,296      
Net loss (6,781,161) (6,781,161)
Balance at Sep. 30, 2019 $ 13,494 15,987,799 (17,238,871) (1,237,578)
Balance, shares at Sep. 30, 2019 13,493,705      
Conversion of convertible notes into common stock $ 7,794 14,172,676 14,180,470
Conversion of convertible notes into common stock, shares 7,793,985      
Issuance costs in connection with conversion of convertible notes into common stock (161,881) (161,881)
Stock-based compensation 798,242 798,242
Issuance of common stock under securities purchase agreement $ 217 389,783 390,000
Issuance of common stock under securities purchase agreement, shares 216,666      
Issuance of warrants in connection with convertible notes offering 696,672 696,672
Issuance of warrants in connection with convertible notes offering, shares      
Issuance of common stock for consulting services $ 427 641,289 641,716
Issuance of common stock for consulting services, shares 426,583      
Issuance of common stock upon vesting of restricted stock units $ 173 395,839 396,012
Issuance of common stock upon vesting of restricted stock units, shares 173,190      
Exercise of stock options $ 76 2,603 2,679
Exercise of stock options, shares 76,545      
Net loss (13,640,160) (13,640,160)
Balance at Sep. 30, 2020 $ 22,181 $ 32,923,022 $ (30,879,031) $ 2,066,172
Balance, shares at Sep. 30, 2020 22,180,674